QDEL

$QDEL chatter on StockTwits

• 
  Adam@AdamInvest23h

  $QDEL smart plays down

  View on StockTwits ↗
• 
  Hov@OnlyFibsBullish3d

  QuidelOrtho Corporation $QDEL (8h) Bullish Flow: Heavy institutional accumulation is actively building a base around local demand, as smart money bids absorb selling pressure along the lower channel trendline. 🐂 💧 Bull Key Level: $13.45 (Bull confirmation to break descending trendline resistance and trigger momentum expansion) 🐂 🔥 Bear Key Level: $11.40 (Key structural support floor and critical multi-week demand zone to defend) 🐻 ⚠️ Targets: $21.44 / $29.34 💰 🍺 Why: The 8-hour chart is compressing tightly within a falling wedge directly into major historical demand. Defending $11.40 keeps the broader reversal structural thesis intact, paving the way for a high-volume breakout expansion toward overhead targets at $21.44 and $29.34. #qdel | #quidelortho | #healthcare | #stocktrading | #hovdid

  View on StockTwits ↗
• 
  BullYa@BullYa6d

  $QDEL retest 📉 $9.92 was the bottom 🔥

  View on StockTwits ↗
• 
  Alex C.@Chickenstick16d

  $QDEL Good report but one of the worst guides I've seen this cycle. Mea Culpa . The company needs to strip out China and offer US pro forma metrics from here on. China was always a risk that management, obviously, didn't take serious enough-- and I, too, am a little dumbfounded. No news on the spin out-- WTF. I am rarely this wrong on a name. Beyond that, I dont know what to say besides: they should've preannounced this guide. Obviously the stock at 1X-2X adjusted EBITDA represents extreme value ( which is why the Spin-out makes sense), but I may no be along for the ride. Again, Mea Culpa.

  View on StockTwits ↗
• 
  DonCorleone77@DonCorleone77Aug 7

  $CART $DV $TTD $QDEL $XPOF AFTER-HOURS MOVERS: Currently Higher After Earnings: Doximity (DOCS) up 73.8% Atlassian (TEAM) up 32.9% Figs (FIGS) up 23.7% QuinStreet (QNST) up 27.9% Cloudflare (NET) up 16.2% Twilio (TWLO) up 17.0% Natera (NTRA) up 15.4% Akamai (AKAM) up 12.1% Onto Innovation (ONTO) up 13.0% Airbnb (ABNB) up 7.8% Instacart (CART) up 9.9% Currently Also Higher: DoubleVerify (DV) up 13.2% after Nielsen agreed to acquire the company in an all-cash transaction valued at roughly $2.15B Currently Lower After Earnings: Trade Desk (TTD) down 24.3% QuidelOrtho (QDEL) down 23.1% Xponential Fitness (XPOF) down 12.7% Cable One (CABO) down 9.5% Maravai Lifesciences (MRVI) down 7.2% ResMed (RMD) down 5.9% 10x Genomics (TXG) down 3.5% Dropbox (DBX) down 6.5%. Post Holdings (POST) down 2.6%

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsAug 6

  $QDEL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.36 up 63.93% YoY • Reported revenue of $630.9M up 2.77% YoY • QuidelOrtho updated full-year 2026 financial guidance, now projecting total revenues of $2.52-$2.60 billion, adjusted EBITDA of $540-$560 million, and adjusted diluted EPS of $0.65-$0.90, while withdrawing free cash flow guidance.

  View on StockTwits ↗
• 
  Alex C.@Chickenstick1Aug 6

  $QDEL I like this into earnings.

  View on StockTwits ↗
• 
  Hov@OnlyFibsBullishJul 21

  As a world-leading diagnostics enterprise advancing immunoassay and molecular testing, $QDEL is showing strong technical respect for its lower range support. The 8 hour chart highlights a potential double bottom reaction around 16.45 dollars as accumulation builds. 🐂🎯 Bull Key Levels: Need to see a clean push through 17.50 dollars to ignite fresh buying volume and trap late short sellers. 🐂🔥 Bear Key Levels: If the 15.80 dollar level fails to hold, expect the price to retest lower channel boundaries. 🐻⚠️ Take Profit Targets: 19.50 / 21.50 dollars. 💰💸 #hovdid $QDEL #healthcare #stocks #investing

  View on StockTwits ↗
• 
  Alex C.@Chickenstick1Jul 17

  $QDEL Well, you heard what $ABT had to say. I certainly like the opportunity to accumulate into earnings.

  View on StockTwits ↗
• 
  Alex C.@Chickenstick1Jul 16

  $QDEL Good read-through from ABT.

  View on StockTwits ↗
• 
  Squeezy@TheRealShortSqueezyBullishJul 15

  🧬 $INBS : Could FDA Approval Unlock the Next Leg Higher? Intelligent Bio Solutions is developing a fingerprint based drug screening system that delivers fast, non invasive testing On June 16, the company kicked off another FDA clinical study, marking another step toward its planned 510(k) submission and potential entry into the U.S. drug testing market Recent Highlights: 🔹 FDA clinical program remains on track 🔹 135-patient U.S. multi site study underway 🔹 Operating in 35+ countries with 480+ active customer accounts 🔹 Q3 revenue increased 46% YoY to $1.06M 🔹 Nine-month revenue reached $3.07M, up 39% YoY 🔹 Gross margin climbed above 50% 🔹 Cash position increased to $6.86M 🔹 Secured its 8th European patent while expanding manufacturing capacity With several FDA milestones ahead, growing commercial traction, and improving financials, INBS looks like one to keep on the watchlist Communicated Disclaimer: https://stockresearchtoday.com/inbs/ Sector Peers : $OSUR $QDEL $DGX $LH

  View on StockTwits ↗
• 
  Alex C.@Chickenstick1Jul 14

  $QDEL Depending on what they can get for their in office test business, I think this can trade above $30. I bet $ABT makes a bid because they have the cash and manufacturing footprint to make it an extremely profitable segment. But, as for $QDEL the divestiture will immediately make them FCF positive.

  View on StockTwits ↗
• 
  Runitback@runitback349BullishJul 6

  $QDEL pretty bullish consolidation no?

  View on StockTwits ↗
• 
  Nicholas@JFDIBullishJul 1

  $QDEL post eps drift

  View on StockTwits ↗
• 
  Alex C.@Chickenstick1Jun 30

  $QDEL haha the bears are just way too complacent . If they spin or sell the POC test business, it improves just about every metric. They should do it. Shares would more than double from here and still trade at a discount to the industry. Accumulate into earnings.

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.